Viking Therapeutics (VKTX) Reports Q3 Loss of $0.08

Go back to Viking Therapeutics (VKTX) Reports Q3 Loss of $0.08
ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) Delayed: 35.36 +2.99 (9.24%)
Previous Close $32.37    52 Week High $5.17 
Open $31.76    52 Week Low $0.94 
Day High $35.69    P/E N/A 
Day Low $31.76    EPS $0.00 
Volume 2,804,337